Literature DB >> 24500981

High hydrostatic pressure induces immunogenic cell death in human tumor cells.

Jitka Fucikova1, Irena Moserova, Iva Truxova, Ivana Hermanova, Irena Vancurova, Simona Partlova, Anna Fialova, Ludek Sojka, Pierre-Francois Cartron, Milan Houska, Lukas Rob, Jirina Bartunkova, Radek Spisek.   

Abstract

Recent studies have identified molecular events characteristic of immunogenic cell death (ICD), including surface exposure of calreticulin (CRT), the heat shock proteins HSP70 and HSP90, the release of high-mobility group box protein 1 (HMGB1) and the release of ATP from dying cells. We investigated the potential of high hydrostatic pressure (HHP) to induce ICD in human tumor cells. HHP induced the rapid expression of HSP70, HSP90 and CRT on the cell surface. HHP also induced the release of HMGB1 and ATP. The interaction of dendritic cells (DCs) with HHP-treated tumor cells led to a more rapid rate of DC phagocytosis, upregulation of CD83, CD86 and HLA-DR and the release of interleukin IL-6, IL-12p70 and TNF-α. DCs pulsed with tumor cells killed by HHP induced high numbers of tumor-specific T cells. DCs pulsed with HHP-treated tumor cells also induced the lowest number of regulatory T cells. In addition, we found that the key features of the endoplasmic reticulum stress-mediated apoptotic pathway, such as reactive oxygen species production, phosphorylation of the translation initiation factor eIF2α and activation of caspase-8, were activated by HHP treatment. Therefore, HHP acts as a reliable and potent inducer of ICD in human tumor cells.
© 2014 UICC.

Entities:  

Keywords:  cancer immunotherapy; dendritic cells; heat shock proteins; high hydrostatic pressure; immunogenic cell death

Mesh:

Substances:

Year:  2014        PMID: 24500981     DOI: 10.1002/ijc.28766

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  66 in total

1.  Severe, but not mild heat-shock treatment induces immunogenic cell death in cancer cells.

Authors:  Irena Adkins; Lenka Sadilkova; Nada Hradilova; Jakub Tomala; Marek Kovar; Radek Spisek
Journal:  Oncoimmunology       Date:  2017-03-31       Impact factor: 8.110

2.  Caspase-2 and oxidative stress underlie the immunogenic potential of high hydrostatic pressure-induced cancer cell death.

Authors:  Irena Moserova; Iva Truxova; Abhishek D Garg; Jakub Tomala; Patrizia Agostinis; Pierre Francois Cartron; Sarka Vosahlikova; Marek Kovar; Radek Spisek; Jitka Fucikova
Journal:  Oncoimmunology       Date:  2016-11-18       Impact factor: 8.110

3.  Immunological metagene signatures derived from immunogenic cancer cell death associate with improved survival of patients with lung, breast or ovarian malignancies: A large-scale meta-analysis.

Authors:  Abhishek D Garg; Dirk De Ruysscher; Patrizia Agostinis
Journal:  Oncoimmunology       Date:  2015-08-12       Impact factor: 8.110

Review 4.  Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy.

Authors:  Jonathan Pol; Erika Vacchelli; Fernando Aranda; Francesca Castoldi; Alexander Eggermont; Isabelle Cremer; Catherine Sautès-Fridman; Jitka Fucikova; Jérôme Galon; Radek Spisek; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2015-03-02       Impact factor: 8.110

Review 5.  Immunogenic cell death in cancer and infectious disease.

Authors:  Lorenzo Galluzzi; Aitziber Buqué; Oliver Kepp; Laurence Zitvogel; Guido Kroemer
Journal:  Nat Rev Immunol       Date:  2016-10-17       Impact factor: 53.106

Review 6.  Key mechanisms involved in ionizing radiation-induced systemic effects. A current review.

Authors:  Ifigeneia V Mavragani; Danae A Laskaratou; Benjamin Frey; Serge M Candéias; Udo S Gaipl; Katalin Lumniczky; Alexandros G Georgakilas
Journal:  Toxicol Res (Camb)       Date:  2015-08-11       Impact factor: 3.524

7.  Exploiting a new strategy to induce immunogenic cell death to improve dendritic cell-based vaccines for lymphoma immunotherapy.

Authors:  B Montico; C Lapenta; M Ravo; D Martorelli; E Muraro; B Zeng; E Comaro; M Spada; S Donati; S M Santini; R Tarallo; G Giurato; F Rizzo; A Weisz; F Belardelli; R Dolcetti; J Dal Col
Journal:  Oncoimmunology       Date:  2017-07-31       Impact factor: 8.110

8.  Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure inhibit prostate tumor growth in TRAMP mice.

Authors:  Romana Mikyskova; Marie Indrova; Ivan Stepanek; Ivan Kanchev; Jana Bieblova; Sarka Vosahlikova; Irena Moserova; Iva Truxova; Jitka Fucikova; Jirina Bartunkova; Radek Spisek; Radislav Sedlacek; Milan Reinis
Journal:  Oncoimmunology       Date:  2017-08-24       Impact factor: 8.110

9.  Induction of Immunogenic Cell Death in Lymphoma Cells by Wharton's Jelly Mesenchymal Stem Cell Conditioned Medium.

Authors:  Daniel Hao Lin; Arijit Biswas; Mahesh Choolani; Chui-Yee Fong; Ariff Bongso
Journal:  Stem Cell Rev Rep       Date:  2017-12       Impact factor: 5.739

10.  Personalized ex vivo multiple peptide enrichment and detection of T cells reactive to multiple tumor-associated antigens in prostate cancer patients.

Authors:  Pavla Taborska; Dmitry Stakheev; Zuzana Strizova; Katerina Vavrova; Michal Podrazil; Jirina Bartunkova; Daniel Smrz
Journal:  Med Oncol       Date:  2017-09-02       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.